Abstract:Although a critical role for caveolae-mediated albumin transcytosis in pulmonary endothelium is well established, considerably less is known about caveolae-independent pathways. In this current study, we confirmed that cultured rat pulmonary microvascular (RPMEC) and pulmonary artery (RPAEC) endothelium endocytosed Alexa488-labeled albumin in a saturable, temperature-sensitive mode and internalization resulted in co-localization by fluorescence microscopy with cholera B toxin and caveolin-1. Although siRNA to … Show more
“…Fluorophore labeled conjugates were diluted to desired concentrations, centrifuged to remove potential particulates, and vortex mixed prior to treatment. These labeled macromolecules were selected as specific makers: CTB for caveolar vesicles, Tfn for clathrin-coated vesicles, BSA for receptor-mediated vesicular uptake and Dex as a marker for non-specific endocytosis including micro- and macropinocytosis [18, 20, 26, 31–36]. …”
Section: Methodsmentioning
confidence: 99%
“…Two types of vesicles that may be involved with receptor-mediated fluid transport are caveolar and clathrin-coated vesicles [18–25]. Caveolae are involved in many biological processes including endocytosis and transcytosis and play a major role in transcellular albumin transport [18, 20, 26].…”
Section: Introduction1mentioning
confidence: 99%
“…Caveolae are involved in many biological processes including endocytosis and transcytosis and play a major role in transcellular albumin transport [18, 20, 26]. Clathrin-coated vesicles endocytose fluid, various proteins, essential nutrients and ions, playing a role in cell homeostasis as well as transcellular transport [27–29].…”
Section: Introduction1mentioning
confidence: 99%
“…Our objectives were to use specific fluorophore-labeled macromolecules as markers of receptor mediated and non-receptor mediated vesicular uptake [18, 20, 26, 31–36] to 1) determine whether caveolar and/or clathrin-coated vesicles are present in human amnion cells, 2) analyze the kinetic characteristics of vesicle uptake and 3) determine the spatial distribution of vesicles within amnion cells. Placental amnion cells were used for the study as transport of amniotic fluid and solutes into fetal blood occurs across the placental rather than across the reflected amnion [5, 16].…”
Introduction
Studies in animal models have shown that unidirectional vesicular transport of amniotic fluid across the amnion plays a primary role in regulating amniotic fluid volume. Our objective was to explore vesicle type, vesicular uptake and intracellular distribution of vesicles in human amnion cells using high- and super-resolution fluorescence microscopy.
Methods
Placental amnion was obtained at cesarean section and amnion cells were prepared and cultured. At 20%–50% confluence, the cells were incubated with fluorophore conjugated macromolecules for 1–30 minutes at 22°C or 37°C. Fluorophore labeled macromolecules were selected as markers of receptor-mediated caveolar and clathrin-coated vesicular uptake as well as non-specific endocytosis. After fluorophore treatment, the cells were fixed, imaged and vesicles counted using Imaris® software.
Results
Vesicular uptake displayed first order saturation kinetics with half saturation times averaging 1.3 minutes at 37°C compared to 4.9 minutes at 22°C, with non-specific endocytotic uptake being more rapid at both temperatures. There was extensive cell-to-cell variability in uptake rate. Under super-resolution microscopy, the pattern of intracellular spatial distribution was distinct for each macromolecule. Co-localization of fluorescently labeled macromolecules was very low at vesicular dimensions.
Conclusions
In human placental amnion cells, 1) vesicular uptake of macromolecules is rapid, consistent with the concept that vesicular transcytosis across the amnion plays a role in the regulation of amniotic fluid volume; 2) uptake is temperature dependent and variable among individual cells; 3) the unique intracellular distributions suggest distinct functions for each vesicle type; 4) non-receptor mediated vesicular uptake may be a primary vesicular uptake mechanism.
“…Fluorophore labeled conjugates were diluted to desired concentrations, centrifuged to remove potential particulates, and vortex mixed prior to treatment. These labeled macromolecules were selected as specific makers: CTB for caveolar vesicles, Tfn for clathrin-coated vesicles, BSA for receptor-mediated vesicular uptake and Dex as a marker for non-specific endocytosis including micro- and macropinocytosis [18, 20, 26, 31–36]. …”
Section: Methodsmentioning
confidence: 99%
“…Two types of vesicles that may be involved with receptor-mediated fluid transport are caveolar and clathrin-coated vesicles [18–25]. Caveolae are involved in many biological processes including endocytosis and transcytosis and play a major role in transcellular albumin transport [18, 20, 26].…”
Section: Introduction1mentioning
confidence: 99%
“…Caveolae are involved in many biological processes including endocytosis and transcytosis and play a major role in transcellular albumin transport [18, 20, 26]. Clathrin-coated vesicles endocytose fluid, various proteins, essential nutrients and ions, playing a role in cell homeostasis as well as transcellular transport [27–29].…”
Section: Introduction1mentioning
confidence: 99%
“…Our objectives were to use specific fluorophore-labeled macromolecules as markers of receptor mediated and non-receptor mediated vesicular uptake [18, 20, 26, 31–36] to 1) determine whether caveolar and/or clathrin-coated vesicles are present in human amnion cells, 2) analyze the kinetic characteristics of vesicle uptake and 3) determine the spatial distribution of vesicles within amnion cells. Placental amnion cells were used for the study as transport of amniotic fluid and solutes into fetal blood occurs across the placental rather than across the reflected amnion [5, 16].…”
Introduction
Studies in animal models have shown that unidirectional vesicular transport of amniotic fluid across the amnion plays a primary role in regulating amniotic fluid volume. Our objective was to explore vesicle type, vesicular uptake and intracellular distribution of vesicles in human amnion cells using high- and super-resolution fluorescence microscopy.
Methods
Placental amnion was obtained at cesarean section and amnion cells were prepared and cultured. At 20%–50% confluence, the cells were incubated with fluorophore conjugated macromolecules for 1–30 minutes at 22°C or 37°C. Fluorophore labeled macromolecules were selected as markers of receptor-mediated caveolar and clathrin-coated vesicular uptake as well as non-specific endocytosis. After fluorophore treatment, the cells were fixed, imaged and vesicles counted using Imaris® software.
Results
Vesicular uptake displayed first order saturation kinetics with half saturation times averaging 1.3 minutes at 37°C compared to 4.9 minutes at 22°C, with non-specific endocytotic uptake being more rapid at both temperatures. There was extensive cell-to-cell variability in uptake rate. Under super-resolution microscopy, the pattern of intracellular spatial distribution was distinct for each macromolecule. Co-localization of fluorescently labeled macromolecules was very low at vesicular dimensions.
Conclusions
In human placental amnion cells, 1) vesicular uptake of macromolecules is rapid, consistent with the concept that vesicular transcytosis across the amnion plays a role in the regulation of amniotic fluid volume; 2) uptake is temperature dependent and variable among individual cells; 3) the unique intracellular distributions suggest distinct functions for each vesicle type; 4) non-receptor mediated vesicular uptake may be a primary vesicular uptake mechanism.
“…It is important to note that inhibitors of the TGF-β type II pathway may have the opposite effect on drug delivery by inhibiting endocytosis of albumin-bound agents. Caveolae are also involved in albumin transcytosis by endothelial cells (47); however, how they respond to TGF-β inhibitors remains unknown, and such mechanisms are beyond the scope of this manuscript.…”
Limited transendothelial permeability across tumor microvessels represents a significant bottleneck in the development of tumor-specific diagnostic agents and theranostic drugs. Here, we show an approach to increase transendothelial permeability of macromolecular and nanoparticle-based contrast agents via inhibition of the type I TGF-β receptor, activin-like kinase 5 (Alk5), in tumors. Alk5 inhibition significantly increased tumor contrast agent delivery and enhancement on imaging studies, while healthy organs remained relatively unaffected. Imaging data correlated with significantly decreased tumor interstitial fluid pressure, while tumor vascular density remained unchanged. This immediately clinically translatable concept involving Alk5 inhibitor pretreatment prior to an imaging study could be leveraged for improved tumor delivery of macromolecular and nanoparticle-based imaging probes and, thereby, facilitate development of more sensitive imaging tests for cancer diagnosis, enhanced tumor characterization, and personalized, image-guided therapies.
Engineered nanomaterials (NMs) are increasingly fabricated in various fields involving consumer goods, waste management, and biomedical applications such as drug delivery, diagnosis, and treatment of pathological conditions. While these NMs are intentionally or unexpectedly in contact with the human body, there are growing concerns about their intracellular journey, especially considering the therapeutic or deleterious effects after they cross the cell membrane. In this review, the cellular journey of NMs including internalization, intracellular trafficking, and deposition/exocytosis is systematically discussed. This work highlights the accumulation of NMs in cells not only depends on the moment of NMs crossing the cell membrane but also at the following trafficking and exocytosis process. A deeper understanding of the cellular journey of NMs implies that an alternative strategy to fabricate specific targeting NMs is to bypass a few pathways of intracellular trafficking to achieve potent therapeutic effects with minimal toxicity. After comprehensively reviewing the cellular journey of NMs, current progress and application scenarios of kinetic models are discussed. Finally, this review focuses on the bottleneck problems and the corresponding solution technologies for studying the cellular journey of NMs. Recent progresses on the cellular journey of NMs provide new insights into the fabrication of biomedical NMs and facilitate technology development for probing the nano‐cell interaction with high temporal‐spatial resolution.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.